Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

BNGO

Bionano Genomics (BNGO)

Bionano Genomics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BNGO
DateHeureSourceTitreSymboleSociété
10/06/202423h12Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BNGOBionano Genomics Inc
05/06/202423h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BNGOBionano Genomics Inc
05/06/202420h59Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:BNGOBionano Genomics Inc
30/05/202414h00GlobeNewswire Inc.Bionano Announces Robust Presence at Upcoming Cytogenetics Conferences ESHG and ACC with 39 Scientific Presentations and Posters Highlighting the Utility of the Optical Genome Mapping WorkflowNASDAQ:BNGOBionano Genomics Inc
28/05/202414h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNGOBionano Genomics Inc
28/05/202414h00GlobeNewswire Inc.Bionano Announces Private Placement of Senior Secured Notes in Debt Restructuring that Improves Balance SheetNASDAQ:BNGOBionano Genomics Inc
21/05/202414h00GlobeNewswire Inc.Bionano Announces Three Publications Demonstrating OGM’s Utility for Cell and Gene TherapyNASDAQ:BNGOBionano Genomics Inc
09/05/202414h00GlobeNewswire Inc.Bionano Announces Series of Major Advancements to its Suite of Computational Tools for Comprehensive Cancer AnalysisNASDAQ:BNGOBionano Genomics Inc
08/05/202423h27Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BNGOBionano Genomics Inc
08/05/202422h09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BNGOBionano Genomics Inc
08/05/202422h01GlobeNewswire Inc.Bionano Reports First Quarter 2024 Results and Highlights Recent Business ProgressNASDAQ:BNGOBionano Genomics Inc
01/05/202414h00GlobeNewswire Inc.Bionano to Report First Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 8, 2024NASDAQ:BNGOBionano Genomics Inc
30/04/202422h05GlobeNewswire Inc.Bionano to Present at the RBC Capital Markets 2024 Global Healthcare ConferenceNASDAQ:BNGOBionano Genomics Inc
24/04/202414h00GlobeNewswire Inc.Bionano Announces Publication Showing OGM’s High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore SequencingNASDAQ:BNGOBionano Genomics Inc
17/04/202414h00GlobeNewswire Inc.Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial IntelligenceNASDAQ:BNGOBionano Genomics Inc
11/04/202414h00GlobeNewswire Inc.Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome SequencingNASDAQ:BNGOBionano Genomics Inc
04/04/202419h44GlobeNewswire Inc.Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesNASDAQ:BNGOBionano Genomics Inc
03/04/202414h00GlobeNewswire Inc.Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical CytogeneticsNASDAQ:BNGOBionano Genomics Inc
02/04/202414h00GlobeNewswire Inc.Bionano Announces 9 Poster Presentations and Introduces New High Throughput Stratys™ System at the American Association for Cancer Research Annual MeetingNASDAQ:BNGOBionano Genomics Inc
19/03/202413h00GlobeNewswire Inc.Bionano Announces Publication of a Breast Cancer Study Showing that the Number of SVs Detected with OGM May Be Related to Prognosis, Tumor Progression and Chemotherapy ResistanceNASDAQ:BNGOBionano Genomics Inc
07/03/202414h00GlobeNewswire Inc.Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Including Live Product Showcase Featuring the Company’s New Stratys™ SystemNASDAQ:BNGOBionano Genomics Inc
05/03/202423h26Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:BNGOBionano Genomics Inc
05/03/202422h01GlobeNewswire Inc.Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024NASDAQ:BNGOBionano Genomics Inc
29/02/202414h00GlobeNewswire Inc.Bionano to Present at TD Cowen’s 44th Annual Health Care ConferenceNASDAQ:BNGOBionano Genomics Inc
28/02/202414h01GlobeNewswire Inc.Bionano to Report Fourth Quarter and Year End 2023 Financial Results and Host a Conference Call and Webcast on March 5, 2024NASDAQ:BNGOBionano Genomics Inc
28/02/202414h00GlobeNewswire Inc.Bionano Announces Amendment to Debt Financing Arrangement to Extend Cash RunwayNASDAQ:BNGOBionano Genomics Inc
22/02/202414h00GlobeNewswire Inc.American College of Medical Genetics and Genomics Includes OGM in Latest Edition of Technical Laboratory Standards for Solid Tumor AnalysisNASDAQ:BNGOBionano Genomics Inc
31/01/202414h00GlobeNewswire Inc.Bionano to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceNASDAQ:BNGOBionano Genomics Inc
30/01/202414h00GlobeNewswire Inc.Bionano’s Symposium 2024 Featured Presentations from its Global User Community Highlighting OGM as a Powerful Alternative to Classical Cytogenetics and Strong Complement to NGSNASDAQ:BNGOBionano Genomics Inc
24/01/202414h00GlobeNewswire Inc.Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal TestingNASDAQ:BNGOBionano Genomics Inc
 Showing the most relevant articles for your search:NASDAQ:BNGO